Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit

ConclusionThe use of NAC and the incidence of 'BCS after NAC′ increased exponentially in time for all stages of invasive breast cancer in the Netherlands. This nationwide data confirms that 'BCS after NAC′ compared to 'primary BCS′ leads to equal surgical outcomes for cT2 and improved surgical outcomes for cT3 breast cancer. These promising results encourage current developments towards de-escalation of surgical treatment.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research